Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the Gene

The traditional Chinese medicine formula Jianpi-Huayu (JPHY) has been reported to be effective in the treatment of hepatocellular carcinoma (HCC). However, its underlying mechanism remains unclear. In this article, we employed an orthotopic transplantation model in nude mice to explore whether JPHY...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yajing Huang MD, Cheng Zhou MD, Huihong Wen MD, Yongxu Chen MD, Yingjie Xie MD, Xiaohe Lan MD, Juze Lin MD, PhD, Xuhui Huang MD, Yousheng Mo MD, PhD, Cong Yang MD, PhD, Qi Wang MD, PhD, Changjun Wang MD, PhD
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	SAGE Publishing 2020-02-01
סדרה:	Integrative Cancer Therapies
גישה מקוונת:	https://doi.org/10.1177/1534735419900804
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!